Fig. 3. Changes in abdominal pain (A) and discomfort (B), stool consistency (C), and bowel movement (D) at weeks 1, 2, 3, and 4 compared to the baseline. Compared to the placebo group, the decrease abdominal pain score in the DA-9701 group tended to be higher, and the decrease at week 3 was significantly higher in the DA-9701 group (P = 0.042). Change 1 = 1 week – baseline; Change 2 = 2 weeks – baseline; Change 3 = 3 weeks – baseline; Change 4 = 4 weeks - baseline. *P < 0.05.
© J Neurogastroenterol Motil
